A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

The first vaccines are due to be produced at the new facility in 2025. It also said the alliance will see Moderna invest in R&D in the UK over the next 10 years, including running a number of ...

RFK Jr.'s dismissal of vaccine science during Senate hearings raises concerns about his fitness for HHS secretary role. (AP/Rod Lamkey, Jr.) Kennedy dismissed scientific evidence on vaccine safety ...

Sure, there are some topics that seem to lend themselves appropriately to opinion pages. Vaccines, however, which have prevented 6 million deaths every year worldwide and have fundamentally ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 ...

RNA vaccines are composed of the nucleic acid RNA, which encode antigen genes of an infectious agent. When administered to host cells, the RNA is translated into protein antigens that elicit ...